Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$134K Buy
2,776
+968
+54% +$49.4K ﹤0.01% 463
2026
Q2
$94.8K Sell
1,808
-3
-0.2% -$159 ﹤0.01% 515
2026
Q1
$100K Sell
1,811
-3
-0.2% -$163 ﹤0.01% 468
2025
Q4
$89K Buy
1,814
+3
+0.2% +$140 ﹤0.01% 479
2025
Q3
$78.2K Buy
1,811
+783
+76% +$30.6K ﹤0.01% 485
2025
Q2
$39.5K Sell
1,028
-398
-28% -$15.2K ﹤0.01% 582
2025
Q1
$55.2K Buy
1,426
+518
+57% +$19K ﹤0.01% 537
2024
Q4
$30.7K Buy
908
+280
+45% +$10.1K ﹤0.01% 625
2024
Q3
$25.7K Buy
+628
New +$25.7K ﹤0.01% 649
2015
Q3
– Sell
-44,572
Closed -$2.32M – 205
2015
Q2
$2.32M Buy
44,572
+1,054
+2% +$59.3K 0.19% 85
2015
Q1
$2.51M Sell
43,518
-685
-2% -$39.3K 0.2% 85
2014
Q4
$2.36M Buy
44,203
+102
+0.2% +$5.71K 0.19% 86
2014
Q3
$2.53M Buy
44,101
+10,014
+29% +$614K 0.2% 83
2014
Q2
$2.28M Buy
+34,087
New +$2.31M 0.18% 87

Other funds holding GSK

Eastern Bank's GSK Position: Q3 2026 in Review

Eastern Bank increased its GSK (GSK) stake by 54% in Q3 2026, buying an estimated $49.4K and bringing the position to 2,776 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #463.

Eastern Bank first reported a position in GSK in Q2 2014 and has held it in 14 quarters since. The position peaked at $2.53M in Q3 2014. 272 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Eastern Bank held 2,776 shares of GSK worth $134K as of Q3 2026.
  • Eastern Bank bought 968 GSK shares in Q3 2026, an estimated $49.4K.
  • GSK made up ﹤0.01% of Eastern Bank's portfolio in Q3 2026, its #463 holding.
  • Eastern Bank first reported a position in GSK in Q2 2014 and has held it in 14 quarters since.
  • Eastern Bank's GSK position peaked at $2.53M in Q3 2014.
  • 272 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Eastern Bank's 13F filing for Q3 2026, filed 5 Oct 2026.